Skip to search formSkip to main contentSkip to account menu

Pneumococcal vaccine

Known as: Pneumococcal Vaccines, pneumococcal, unspecified formulation, Streptococcus pneumoniae Vaccine 
Vaccines or candidate vaccines used to prevent infections with STREPTOCOCCUS PNEUMONIAE.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Patients with chronic obstructive pulmonary diseases (COPD) are frequently exposed to infectious agents including influenza virus… 
2014
2014
Streptococcus pneumoniae is the leading bacterial cause of pneumococcal diseases, of which pneumonia is the main cause of death… 
2013
2013
Drug or vaccine safety is the prime concern in clinical trials along with theoverall efficacy. Consequently, it is worthwhile to… 
2008
2001
2001
Controversy continues about the effectiveness of the pneumococcal vaccine in preventing disease in HIV-positive patients… 
2000
2000
OBJECTIVE: To study the immunogenicity of the 23-valent pneumoccal vaccine in children with chronic renal disease and in those… 
1988
1988
  • Cer
  • 1988
  • Corpus ID: 80324539
The efficacy of pneumococcal vaccine, especially in the elderly, is controversial. Several studies, both pro and con, have… 
1981
1981
High-risk patients who should receive the pneumococcal vaccine include asplenic patients, those with sickle cell anemia… 
Review
1979
Review
1979
  • W. Rosser
  • 1979
  • Corpus ID: 35456803
In March 1978 pneumococcal vaccine became available on the Canadian market. The prescribing information supplied by the drug…